Enfortumab Vedotin-Ejfv For Injection 43624-0023
Product NDC
43624-0023- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- January 5, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Enfortumab Vedotin-Ejfv | 30 mg/2mL |
Packaging Options(1)
120 VIAL, SINGLE-DOSE in 1 TRAY (43624-023-01) / 2 mL in 1 VIAL, SINGLE-DOSE